Dosimetric Comparison of Intensity-Modulated Radiosurgery and Helical Tomotherapy for the Treatment of Multiple Intracranial Metastases

Author:

VanderSpek Lauren1,Bauman Glenn2,Wang Jia-Zhu3,Yartsev Slav1,Ménard Cynthia4,Cho Young-Bin4,Mundt Arno J.3,Lawson Joshua D.3,Murphy Kevin T.3

Affiliation:

1. Department of Radiation Oncology London Regional Cancer Program University of Western Ontario 790 Commissioners Rd. E. London ON, N6A 4L6, Canada

2. Department of Oncology, London Regional Cancer Program University of Western Ontario, London ON Canada

3. Department of Radiation Oncology University of California, San Diego La Jolla, CA, USA

4. Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Abstract

The purpose of this study was to evaluate the dosimetry of single fraction, single-isocenter intensity-modulated radiosurgery (IMRS) plans for multiple intracranial metastases and to compare Helical Tomotherapy (HT). Ten treatment plans with 3–6 brain metastases treated with IMRS were re-planned with HT. The mean number of lesions was 5 and mean PTV 22 cm3. The prescribed dose was 16–20 Gy. The mean V100% was similar for IMRS and HT, and the mean conformity index was 1.4, mean Paddick confirmity index was 0.7, and mean MDPD was 1.1 for both. The mean gradient index was similar for both. The mean 50% isodose volume was 179.2 cm3 for IMRS and 277.0 cm3 for HT (p=0.01). The mean maximum doses to organs at risk were lower for IMRS except brainstem and right optic nerve. For brain, the integral dose was 5.1 and 6.8 Gy-kg (p<0.001) and mean dose 4.0 and 5.4 Gy (p<0.001) for IMRS and HT, respectively. The mean treatment times were 23 (IMRS) and 41 (HT) minutes. Conformity and homogeneity indices were equivalent and sparing of the organs at risk was clinically acceptable for both IMRS and HT. Though the gradient index was similar for IMRS and HT, the mean 50% isodose volume and integral dose to normal brain were lower for IMRS as was treatment time.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3